Medicure (MCUJF) Net Income towards Common Stockholders (2009 - 2026)

Medicure's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $282931.8 for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 34.31% year-over-year to $282931.8; the TTM figure through Mar 2026 stood at -$8.2 million (down 858.76% YoY), while the FY2025 annual figure was -$5.1 million, down 569.33% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $282931.8, up from -$6.9 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $4.0 million in Q4 2022, with the low at -$6.9 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is $188346.5 (2023), against an average of -$239223.9.
• Peak annual rise in Net Income towards Common Stockholders reached 1037.96% in 2025, while the deepest fall reached 671.88% in 2025.
• Medicure's Net Income towards Common Stockholders stood at $4.0 million in 2022, then plunged by 128.63% to -$1.1 million in 2023, then advanced by 21.17% to -$896959.0 in 2024, then plunged by 671.88% to -$6.9 million in 2025, then jumped by 104.09% to $282931.8 in 2026.
• Business Quant data shows MCUJF's Net Income towards Common Stockholders at $282931.8 in Q1 2026, -$6.9 million in Q4 2025, and -$1.0 million in Q3 2025.